AGREEMENT AND PLAN OF MERGERMerger Agreement • September 8th, 2021 • Kadmon Holdings, Inc. • Pharmaceutical preparations • Delaware
This Agreement and Plan of Merger (“Agreement”) is made and entered into as of September 7, 2021 (the “Agreement Date”) by and among Sanofi, a French société anonyme (“Parent”), Latour Merger Sub, Inc., a Delaware corporation and wholly owned indirect subsidiary of Parent (“Merger Subsidiary”), and Kadmon Holdings, Inc., a Delaware corporation (the “Company”). Each of Parent, Merger Subsidiary and the Company are referred to herein as a “Party” and collectively as the “Parties”. Certain capitalized terms used in this Agreement are defined in Exhibit A.
Second Amendment to Employment AgreementEmployment Agreement • September 8th, 2021 • Kadmon Holdings, Inc. • Pharmaceutical preparations • New York
This Second Amendment to the Employment Agreement (the “Amendment”) is entered into and effective as of September 7, 2021 (the “Effective Date”) by and between Kadmon Corporation, LLC, a Delaware limited liability company having a principal place of business at 450 East 29th Street, New York, NY 10016 (“Kadmon” or the “Company”) and Steven Meehan, an individual with a mailing address at P.O. Box 493, Alpine, NJ 07620 (“Employee”). Capitalized terms used but not defined herein shall have the meaning provided in the Employment Agreement (defined below).
